Neurol. praxi. 2026;27(3):203-207 | DOI: 10.36290/neu.2026.005

Pain as one of the symptoms of multiple sclerosis

MUDr. Zuzana Rous, Ph.D.
Neurologická klinika Lékařské fakulty Univerzity Palackého a Fakultní nemocnice Olomouc

Pain is a common, but often underestimated symptom of multiple sclerosis (MS). It significantly affects the patient's quality of life, working capacity as well as their mental state. The most common type is neuropathic pain, followed by pain associated with spasticity and nociceptive musculoskeletal pain; moreover, patients with MS tend to develop headaches more frequently. Diagnosing the type of pain and choosing the appropriate treatment are often challenging and require a multidisciplinary approach. The article presents an overview of the pathophysiology, clinical forms, diagnostic options, and current therapeutic approaches to pain management in patients with MS in routine clinical practice.

Keywords: pain, multiple sclerosis, neuropathic pain, spastic pain.

Received: January 13, 2026; Revised: January 13, 2026; Accepted: February 4, 2026; Prepublished online: February 4, 2026; Published: July 20, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rous Z. Pain as one of the symptoms of multiple sclerosis. Neurol. praxi. 2026;27(3):203-207. doi: 10.36290/neu.2026.005.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Purchase PDF - 60 CZK (2.5 EUR)
    will be unlocked 20.7.2027

    References

    1. Abolhasani H, Ansari NN, Naghdi S, et al. Comparing the validity of the Modified Modified Ashworth Scale (MMAS) and the Modified Tardieu Scale (MTS) in the assessment of wrist flexor spasticity in patients with stroke: protocol for a neurophysiological study. BMJ Open. 2012 Nov 19;2(6):e001394. doi: 10.1136/bmjopen-2012-001394 Go to original source...
    2. Alfredsson L, Olsson T. Lifestyle and Environmental Factors in Multiple Sclerosis. Cold Spring Harb Perspect Med. 2019 Apr 1;9(4):a028944. doi: 10.1101/cshperspect.a028944. Go to original source...
    3. Amatya B, Khan F, Song K, et al. Effectiveness of Non-Pharmacological Interventions for Spasticity Management in Multiple Sclerosis: A Systematic Review. Ann Rehabil Med. 2024 Oct;48(5):305-343. doi: 10.5535/arm.240064. Epub 2024 Oct 31. Go to original source... Go to PubMed...
    4. Arnstein P. Assessment of nociceptive versus neuropathic pain in older adults. Medsurg Nurs. 2012 Nov-Dec;21(6):388-9.
    5. Attal N. Bouhassira D. Translational neuropathic pain research. Pain. 2019 May;160(Suppl 1):S23-S28. doi: 10.1097/j.pain.0000000000001522. Go to original source... Go to PubMed...
    6. Chiarotto A, Maxwell LJ, Ostelo RW, et al. Measurement Properties of Visual Analogue Scale, Numeric Rating Scale, and Pain Severity Subscale of the Brief Pain Inventory in Patients With Low Back Pain: A Systematic Review. J Pain. 2019 Mar;20(3):245-263. doi: 10.1016/j.jpain.2018.07.009. Epub 2018 Aug 10. Go to original source... Go to PubMed...
    7. Dobson R and Giovannoni G. Multiple sclerosis - a review. Eur J Neurol. 2019 Jan;26(1):27-40. Epub 2018 Nov 18. DOI: 10.1111/ene.13819. Go to original source... Go to PubMed...
    8. Enns MW, Bernstein CN, Kroeker K, et al.; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease. The association of fatigue, pain, depression and anxiety with work and activity impairment in immune mediated inflammatory diseases. PLoS One. 2018 Jun 7;13(6):e0198975. doi: 10.1371/journal.pone.0198975. PMID: 29879231; PMCID: PMC5991721. Go to original source...
    9. Fernandez O, Costa-Frossard L, Martinez-Ginéz ML, et al. Integrated Management of Multiple Sclerosis Spasticity and Associated Symptoms Using the Spasticity-Plus Syndrome Concept: Results of a Structured Specialists' Discussion Using the Workmat® Methodology. Front Neurol. 2021 Sep 27:12:722801. doi: 10.3389/fneur.2021.722801. eCollection 2021. Go to original source...
    10. Finnerup NB, Kuner R, Jensen TS. Neuropathic Pain: From Mechanisms to Treatment. Physiol Rev. 2021 Jan 1;101(1):259-301. doi: 10.1152/physrev.00045.2019. Epub 2020 Jun 25. Go to original source... Go to PubMed...
    11. Foley PL, Vesterinen HM, Laird BJ, et al. Prevalence and natural history of pain in adults with multiple sclerosis: systematic review and meta-analysis. Pain. 2013 May;154(5):632-642.doi: 10.1016/j.pain.2012.12.002. Epub 2012 Dec 14. Go to original source... Go to PubMed...
    12. Gklinos P, Mitsikosas DD. Headache disorders in multiple sclerosis: Is there an association? A systematic review and meta-analysis. Mult Scler Relat Disord. 2024 May:85:105536. doi: 10.1016/j.msard.2024.105536. Epub 2024 Mar 3. Go to original source... Go to PubMed...
    13. Gwak YS, Hulsebosch CE. Neuronal hyperexcitability: a substrate for central neuropathic pain after spinal cord injury. Curr Pain Headache Rep. 2011 Jun;15(3):215-22. doi: 10.1007/s11916-011-0186-2. Go to original source... Go to PubMed...
    14. Harb A, Margetis K, Kishner S. Modified Ashworth Scale. Last Update: April 4, 2025.
    15. Jensen MP, Dworkin RH, Gammaitoni AR, et al. Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale. J Pain. 2005 Feb;6(2):98-106. doi: 10.1016/j.jpain.2004.11.002. Go to original source...
    16. Kheder A, Nair KPS. Spasticity: pathophysiology, evaluation and management. Pract Neurol. 2012 Oct;12(5):289-98. doi: 10.1136/practneurol-2011-000155. Go to original source...
    17. Kosinski M, Bayliss MS, Bjorner JB et al. A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res. 2003 Dec;12(8):963-74.doi: 10.1023/a:1026119331193. Go to original source... Go to PubMed...
    18. McBenedict B, Goh KS, Chun Chien Yau, et al. Neuropathic Pain Secondary to Multiple Sclerosis: A Narrative Review. Cureus. 2024 Jun 3;16(6):e61587. doi: 10.7759/cureus.61587. eCollection 2024 Jun. Go to original source...
    19. Mustač F, Pašić H, Medić F, et al. Anxiety and Depression as Comorbidities of Multiple Sclerosis. Psychiatr Danub. 2021;33(Suppl. 4):480-485. PMID: 34718269.
    20. Piťha, M. (2023). Roztroušená skleróza - novelizace doporučeného postupu. Společnost všeobecného lékařství ČLS JEP. Available from: https://www.svl.cz/svl-docs/doporucene-postupy/51/roztrousena-skleroza-2023.pdf.
    21. Racke MK, Frohman EM, Frohman T. Pain in Multiple Scle­rosis: Understanding Pathophysiology, Diagnosis, and Management Through Clinical Vignettes. Front Neurol. 2022 Jan 13:12:799698. doi: 10.3389/fneur.2021.799698. eCollection 2021. Go to original source...
    22. Raja SN, Carr DB, Cohen M, et al. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain. 2020;161(9):1976-1982. doi:10.1097/j.pain.0000000000001939. Go to original source...
    23. Rossner J, Andrade DC, Davis KD, et al. Central neuropathic pain. Nat Rev Dis Primers. 2023 Dec 21;9(1):73. doi: 10.1038/s41572-023-00484-9. Go to original source... Go to PubMed...
    24. Scholz J, Finnerup NB, Attal N, et al. The IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain. 2019 Jan;160(1):53-59. doi: 10.1097/j.pain.0000000000001365 Go to original source... Go to PubMed...
    25. Solaro C, Trabucco E, Uccelli MM. Pain and multiple sclerosis: pathophysiology and treatment. Curr Neurol Neurosci Rep. 2013;13(1):320. doi:10.1007/s11910-012-0320-5. Go to original source... Go to PubMed...
    26. Stewart WF, Lipton RB, Dowson AJ. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56(6 Suppl 1):S20-8. doi: 10.1212/wnl.56.suppl_1.s20. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.